This inventor holds 2 USPTO granted patents. Top assignee: Kaneka Corporation. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyogo, JP (2016)
- Takasago, JP (2019)
Company Filing History:
Years Active: 2016-2019
Title: Yoshiyuki Nakano: Innovator in Protein Engineering
Introduction
Yoshiyuki Nakano is a prominent inventor based in Takasago, Japan. He has made significant contributions to the field of protein engineering, particularly in the development of novel ligands for immunoglobulins. His work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Yoshiyuki Nakano holds 2 patents that focus on engineered Protein A ligands. His latest patents include a protein capable of binding specifically to immunoglobulin and an immunoglobulin-binding affinity ligand. The objective of these inventions is to create a novel engineered Protein A ligand that exhibits improved antibody dissociation properties in acidic conditions compared to existing engineered Protein A ligands. The patents detail a protein with an affinity for immunoglobulin, which includes specific amino acid substitutions that enhance its performance.
Career Highlights
Yoshiyuki Nakano is associated with Kaneka Corporation, where he has been instrumental in advancing research in protein engineering. His innovative approaches have led to the development of proteins that demonstrate lower affinity for the Fab region of immunoglobulins, thereby improving their utility in various applications.
Collaborations
Yoshiyuki Nakano has collaborated with notable colleagues, including Masayuki Takano and Keita Iguchi. These collaborations have fostered a productive research environment, leading to advancements in their shared field of expertise.
Conclusion
Yoshiyuki Nakano's contributions to protein engineering, particularly through his patented innovations, highlight his role as a key inventor in the biotechnology sector. His work continues to influence the development of more effective immunoglobulin-binding proteins.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
